Bausch Health is rumored to be looking to sell its Bausch + Lomb business, which will ease bankruptcy concerns and upgrade ...

Detailed price information for Bausch Health Companies Inc (BHC-N) from The Globe and Mail including charting and trades.

Bausch+Lomb ($BLCO), a contact lens supplier, is exploring a sale to address concerns raised by its lenders like Apollo ...

BHC stock rises 14.7% in a week after a report surfaced that the company is in talks with Jefferies Financial Group to push ...

Bausch Health Companies Inc., headquartered in Laval, Canada, is a global player in the healthcare sector, focusing on specialty pharmaceuticals and medical devices. With a broad portfolio, the ...

Bausch Health retained an 88 per cent shareholding in the eye care subsidiary after listing the group in 2022. But it planned ...

Discover Bausch Health's innovative fluid delivery device, featuring a patented piezoelectric actuator for precise ophthalmic medication dispensing. Explore its advanced design!

Bausch Health (NYSE:BHC), The Financial Times reported Saturday. According to people familiar with the matter, the Canadian eyecare firm is working with advisers from Goldman Sachs to evaluate ...

Bausch Health, with $21 billion The eye care giant is projected to generate $4.7 billion in revenue this year, with nearly 60% coming from contact lenses and eye drugs. The potential sale is part ...

The company (BLCO), which was carved out of parent Bausch Health Cos. Inc. (BHC) in 2022, is working with Goldman Sachs to explore a deal and expects to draw interest from private equity firms ...

Berger Montague (Canada) PC, a Toronto-based law firm that focuses on representing investors in cross-border shareholder disputes, has expanded its investigation of Bausch Health Companies ...

Shares of Bausch Health, Inc. BHC gained 14.7% in a week on reports of refinancing its debt to enable the impending sale of its eye care company, Bausch + Lomb BLCO. The industry declined 0.6% ...